Literature DB >> 2840882

Growth of serotypes I and II and variant strains of infectious bursal disease virus in Vero cells.

F S Kibenge1, A S Dhillon, R G Russell.   

Abstract

The growth of five strains of infectious bursal disease virus--three strains of serotype I (SAL, D-78, 2512), one of serotype II (OH), and one variant strain (Variant-A)--were compared in Vero and chicken embryo fibroblast (CEF) cell cultures in order to characterize the replication of different strains of IBDV in Vero cells. For all five virus strains, the latent period in Vero cells ranged from 12 to 18 hr, which was longer than the 4-to-6-hr latent period observed in CEF cultures for strains SAL, D-78, and OH. Virus strains SAL, D-78, and OH, which were examined in both Vero and CEF cultures, also had a more extensive maturation phase and higher yields of virus in Vero than in CEF cultures. Total titers of these viruses of 5.35 to 6.10 log10 TCID50/ml in CEFs occurred 24 to 30 hr postinoculation (PI), although the cytopathic effect (CPE) was not seen until 72 hr PI. By comparison, their total infectious virus titers of 6.85 to 8.35 log10 TCID50/ml in Vero cells occurred from 48 hr PI, coinciding with the appearance of CPE. The growth curve of Variant-A in Vero cells differed from the other viruses by showing steadily rising extracellular and cell-associated virus titers throughout the 72-hr observation period. Only very low titers of Variant-A were obtained in CEF cultures, and thus no growth curve in CEFs was performed.

Entities:  

Mesh:

Year:  1988        PMID: 2840882

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  8 in total

Review 1.  Infectious bursal disease virus: a review of molecular basis for variations in antigenicity and virulence.

Authors:  M M Nagarajan; F S Kibenge
Journal:  Can J Vet Res       Date:  1997-04       Impact factor: 1.310

2.  Selection of an infectious bursal disease virus mutant with increased immunogenicity following passage under humoral immune pressure.

Authors:  M M Nagarajan; F S Kibenge; A López
Journal:  Can J Vet Res       Date:  2001-04       Impact factor: 1.310

3.  Molecular phylodynamics of infectious bursal disease viruses.

Authors:  Aditya A Agnihotri; Sudhakar P Awandkar; Mahesh B Kulkarni; Sambhaji G Chavhan; Ram C Kulkarni; Vishranti G Chavan
Journal:  Virus Genes       Date:  2022-04-18       Impact factor: 2.332

4.  Sequence analysis of the variable VP2 gene of infectious bursal disease viruses passaged in Vero cells.

Authors:  Hyuk Moo Kwon; Soo Joung Kim
Journal:  Virus Genes       Date:  2004-04       Impact factor: 2.332

5.  Formation of virus-like particles when the polyprotein gene (segment A) of infectious bursal disease virus is expressed in insect cells.

Authors:  F S Kibenge; B Qian; E Nagy; J R Cleghorn; D Wadowska
Journal:  Can J Vet Res       Date:  1999-01       Impact factor: 1.310

6.  Adaptation and Molecular Characterization of Two Malaysian Very Virulent Infectious Bursal Disease Virus Isolates Adapted in BGM-70 Cell Line.

Authors:  Nafi'u Lawal; Mohd Hair-Bejo; Siti Suri Arshad; Abdul Rahman Omar; Aini Ideris
Journal:  Adv Virol       Date:  2017-11-05

7.  Growth and replication of infectious bursal disease virus in the DF-1 cell line and chicken embryo fibroblasts.

Authors:  Kaliyaperumal Rekha; Chandran Sivasubramanian; Ill-Min Chung; Muthu Thiruvengadam
Journal:  Biomed Res Int       Date:  2014-05-14       Impact factor: 3.411

8.  Post-infection viral superinfection technology could treat HBV and HCV patients with unmet needs.

Authors:  Tibor Bakacs; Rifaat Safadi; Imre Kovesdi
Journal:  Hepatol Med Policy       Date:  2018-01-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.